J Vet Sci.  2012 Jun;13(2):199-201. 10.4142/jvs.2012.13.2.199.

Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens

• Zanetti FA
• Zajac MP
• Taboga OA
• Calamante

• KMID: 1376195
• DOI: http://doi.org/10.4142/jvs.2012.13.2.199

Abstract

A recombinant modified vaccinia Ankara (MVA) virus expressing mature viral protein 2 (VP2) of the infectious bursal disease virus (IBDV) was constructed to develop MVA-based vaccines for poultry. We demonstrated that this recombinant virus was able to induce a specific immune response by observing the production of anti-IBDV-seroneutralizing antibodies in specific pathogen-free chickens. Besides, as the epitopes of VP2 responsible to induce IBDV-neutralizing antibodies are discontinuous, our results suggest that VP2 protein expressed from MVA-VP2 maintained the correct conformational structure. To our knowledge, this is the first report on the usefulness of MVA-based vectors for developing recombinant vaccines for poultry.

Keyword

chicken immunity; IBDV; MVA; VP2 protein

MeSH Terms

Animals
Antibodies, Viral
Birnaviridae Infections/prevention & control/*veterinary
Cells, Cultured
Chick Embryo
Chickens
Fibroblasts/metabolism
Infectious bursal disease virus/*immunology
Poultry Diseases/*prevention & control/virology
Specific Pathogen-Free Organisms
Vaccinia virus/*genetics/immunology/metabolism
Viral Structural Proteins/genetics/*immunology/metabolism
Viral Vaccines/*immunology